I'm LongbridgeAI, I can summarize articles.PharmX Technologies issued 6,661,187 ordinary shares to CW Retail Holdings, a Sigma Healthcare subsidiary, under their Strategic Alliance Agreement. The issuance was made without a prospectus in compliance with statutory provisions. This move reinforces the partnership and broadens PharmX's capital base, supporting its role as a key infrastructure provider in the ANZ pharmacy supply chain.
An update from PharmX Technologies ( (AU:PHX) ) is now available.
PharmX Technologies has issued 6,661,187 fully paid ordinary shares to CW Retail Holdings, a subsidiary of Sigma Healthcare, under the existing Strategic Alliance Agreement between the two companies. The issuance was undertaken without a prospectus in reliance on statutory provisions, with PharmX confirming it remains compliant with its continuous disclosure and reporting obligations and that no excluded information needs to be disclosed.
The move reinforces the strategic partnership with Sigma Healthcare and slightly broadens PharmX’s capital base, supporting its role as a key infrastructure provider in the pharmacy supply chain. By affirming regulatory compliance and transparency around the share issue, PharmX seeks to reassure investors and stakeholders while continuing to leverage alliances to strengthen its market position in ANZ’s pharmacy technology sector.
More about PharmX Technologies
PharmX Technologies Ltd operates as ANZ’s leading pharmacy ordering platform, providing essential infrastructure for seamless ordering and inventory management across Australia and New Zealand. Connecting a large network of pharmacies, suppliers, and technology vendors, its high-availability platform supports about $20 billion in annual transactions and underpins ordering, eInvoicing, and analytics solutions.
Positioned in a dynamic, evolving healthcare market, PharmX targets sustained growth driven by population and demographic trends and regulatory change. The company aims to expand its addressable market by leveraging its extensive network, proprietary pharmatech solutions, and advanced data capabilities to unlock new revenue opportunities and improve healthcare outcomes across the region.
Average Trading Volume: 375,221
Technical Sentiment Signal: Buy
Current Market Cap: A$69.24M
For a thorough assessment of PHX stock, go to TipRanks’ Stock Analysis page.